Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. The company is headquartered in Durham, North Carolina and currently employs 14,300 full-time employees. The company went IPO on 2023-06-16. The firm is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The firm offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. The company provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The firm manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The firm has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
Ironwood Pharmaceuticals Inc 주요 수익원은 Human Therapeutics이며, 최신 수익 발표에서 수익은 351,410,000입니다. 지역별로는 United States이 Ironwood Pharmaceuticals Inc의 주요 시장이며, 수익은 341,219,110입니다.
Fortrea Holdings Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Ironwood Pharmaceuticals Inc의 순손실은 $0입니다.